Related references
Note: Only part of the references are listed.Oral administration of cyclic glycyl-proline facilitates task learning in a rat stroke model
Hidekazu Kaneko et al.
BEHAVIOURAL BRAIN RESEARCH (2022)
A Phase 1, Open-Label Study to Evaluate the Effects of Food and Evening Dosing on the Pharmacokinetics of Oral Trofinetide in Healthy Adult Subjects
Mona Darwish et al.
CLINICAL DRUG INVESTIGATION (2022)
Design and outcome measures of LAVENDER, a phase 3 study of trofinetide for Rett syndrome
Jeffrey L. Neul et al.
CONTEMPORARY CLINICAL TRIALS (2022)
Relationship between circulating insulin-like growth factor-1 and blood pressure in adults: A systematic review and meta-analysis of observational studies
Lina Leng et al.
GROWTH HORMONE & IGF RESEARCH (2021)
The autocrine regulation of insulin-like growth factor-1 in human brain of Alzheimer?s disease
Dali Kang et al.
PSYCHONEUROENDOCRINOLOGY (2021)
Interplay between Brain Pericytes and Endothelial Cells in Dementia
Tessa Procter et al.
AMERICAN JOURNAL OF PATHOLOGY (2021)
Cyclic glycine-proline normalizes systolic blood pressure in high-fat diet-induced obese male rats
Fengxia Li et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2020)
Alzheimer's Disease and Vascular Aging JACC Focus Seminar
Marta Cortes-Canteli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Hypertension accelerates cerebral tissue PO2 disruption in Alzheimer's disease
Xuecong Lu et al.
NEUROSCIENCE LETTERS (2020)
A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Fragile X Syndrome
Elizabeth Berry-Kravis et al.
PEDIATRIC NEUROLOGY (2020)
Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction
Ernesto Solis et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome
Daniel G. Glaze et al.
NEUROLOGY (2019)
Plasma cyclic glycine proline/IGF-1 ratio predicts clinical outcome and recovery in stroke patients
Dawei Fan et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Cardiovascular risk factors and Parkinson's disease in 500,000 Chinese adults
Jennifer Kizza et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
IGF-1 and cardiovascular disease
Yusuke Higashi et al.
GROWTH HORMONE & IGF RESEARCH (2019)
Cyclic glycine-proline administration normalizes high-fat diet-induced synaptophysin expression in obese rats
Fengxia Li et al.
NEUROPEPTIDES (2019)
Effect of Endogenous Neuropeptide Cycloprolylglycine on GABAA Receptors in Cerebellar Purkinje Cells
I. N. Sharonova et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2019)
Framingham vascular age is associated with worse cognitive performance in the middle-aged and elderly
Abdul Badran et al.
AGING NEUROPSYCHOLOGY AND COGNITION (2019)
The influence of vascular risk factors on cognitive function in early Parkinson's disease
Maxime Doiron et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2018)
The emerging roles of protein homeostasis-governing pathways in Alzheimer's disease
Ji Cheng et al.
AGING CELL (2018)
The association between peripheral total IGF-1, IGFBP-3, and IGF-1/IGFBP-3 and functional and cognitive outcomes in the Mayo Clinic Study of Aging
Alexandra M. V. Wennberg et al.
NEUROBIOLOGY OF AGING (2018)
Supplementation of Blackcurrant Anthocyanins Increased Cyclic Glycine-Proline in the Cerebrospinal Fluid of Parkinson Patients: Potential Treatment to Improve Insulin-Like Growth Factor-1 Function
Dawei Fan et al.
NUTRIENTS (2018)
Cognitive Function and Vascular Risk Factors Among Older African American Adults
Ishan C. Williams et al.
JOURNAL OF IMMIGRANT AND MINORITY HEALTH (2018)
Mild Cognitive Impairment as a Risk Factor for Parkinson's Disease Dementia
Jeroen Hoogland et al.
MOVEMENT DISORDERS (2017)
A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Rett Syndrome
Daniel G. Glaze et al.
PEDIATRIC NEUROLOGY (2017)
IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development
Ann Hellstrom et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Serum IGF-1 is associated with cognitive functions in early, drug-naive Parkinson's disease
Marina Picillo et al.
PLOS ONE (2017)
Neuropeptide Cycloprolylglycine Exhibits Neuroprotective Activity after Systemic Administration to Rats with Modeled Incomplete Global Ischemia and in In Vitro Modeled Glutamate Neurotoxicity
P. Yu. Povarnina et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2016)
Neuropeptide cycloprolylglycine is an endogenous positive modulator of AMPA receptors
T. A. Gudasheva et al.
DOKLADY BIOCHEMISTRY AND BIOPHYSICS (2016)
Maternally Administered Cyclic Glycine-Proline Increases Insulin-Like Growth Factor-1 Bioavailability and Novelty Recognition in Developing Offspring
Gagandeep Singh-Mallah et al.
ENDOCRINOLOGY (2016)
Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population
Krithika Srikanthan et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2016)
Hypertension and lifetime risk of stroke
Tanvir Chowdhury Turin et al.
JOURNAL OF HYPERTENSION (2016)
THE ROLE OF INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) IN BRAIN DEVELOPMENT, MATURATION AND NEUROPLASTICITY
Adam H. Dyer et al.
NEUROSCIENCE (2016)
Stroke Severity Is a Crucial Predictor of Outcome: An International Prospective Validation Study
Natalia S. Rost et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Vascular Health Indices and Cognitive Domain Function: Singapore Longitudinal Ageing Studies
Shir Lynn Lim et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
All in the family: Clueing into the link between metabolic syndrome and hematologic malignancies
Reem Karmali et al.
BLOOD REVIEWS (2015)
The role for IGF-1-derived small neuropeptides as a therapeutic target for neurological disorders
Jian Guan et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Modeling the effect of insulin-like growth factor-1 on human cell growth
Gemma M. A. Phillips et al.
MATHEMATICAL BIOSCIENCES (2015)
Vascular dysfunction in the pathogenesis of Alzheimer's disease - A review of endothelium-mediated mechanisms and ensuing vicious circles
Luigi Yuri Di Marco et al.
NEUROBIOLOGY OF DISEASE (2015)
The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease
Kiwamu Watanabe et al.
MOLECULAR BRAIN (2015)
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug- na_iveParkinson's disease
M. T. Pellecchia et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
Revisiting the Relationship Between Blood Pressure and Insulin- Like Growth Factor-1
Aletta Elisabeth Schutte et al.
HYPERTENSION (2014)
Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010
Valery L. Feigin et al.
LANCET (2014)
The Relationship between Serum Insulin-Like Growth Factor I Levels and Ischemic Stroke Risk
Xiang Dong et al.
PLOS ONE (2014)
Cyclic glycine-proline regulates IGF-1 homeostasis by altering the binding of IGFBP-3 to IGF-1
Jian Guan et al.
SCIENTIFIC REPORTS (2014)
The effects of hypertension on the cerebral circulation
Paulo W. Pires et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naive Parkinson's disease
Marina Picillo et al.
JOURNAL OF NEUROLOGY (2013)
The GH/IGF-1 axis in ageing and longevity
Riia K. Junnila et al.
NATURE REVIEWS ENDOCRINOLOGY (2013)
Age-related memory decline is associated with vascular and microglial degeneration in aged rats
Rong Zhang et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
The Emerging Role of IGF-1 Deficiency in Cardiovascular Aging: Recent Advances
Zoltan Ungvari et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2012)
Aging, Synaptic Dysfunction, and Insulin-Like Growth Factor (IGF)-1
Ferenc Deak et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2012)
Reduced brain insulin-like growth factor I function during aging
Alexandre Pastoris Muller et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2012)
Serum Insulinlike Growth Factor 1 as Possible Marker for Risk and Early Diagnosis of Parkinson Disease
Jana Godau et al.
ARCHIVES OF NEUROLOGY (2011)
Vascular Mechanisms in the Pathogenesis of Stroke
Cristina Sierra et al.
CURRENT HYPERTENSION REPORTS (2011)
Serum IGF-I Levels Correlate to Improvement of Functional Outcome after Ischemic Stroke
Daniel Aberg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study)
W. G. J. Reid et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Liver-spleen axis, insulin-like growth factor-(IGF)-I axis and fat mass in overweight/obese females
Silvia Savastano et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
NNZ-2591, a novel diketopiperazine, prevented scopolamine-induced acute memory impairment in the adult rat
Jian Guan et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Increased serum insulin-like growth factor 1 in early idiopathic Parkinson's disease
Jana Godau et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions
Jian Guan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
A novel diketopiperazine improves functional recovery given after the onset of 6-OHDA-induced motor deficit in rats
R. V. M. Krishnamurthi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Delayed peripheral administration of the N-terminal tripeptide of IGF-1 (GPE) reduces brain damage following microsphere induced embolic damage in young adult and aged rats
Shlomo Shapira et al.
NEUROSCIENCE LETTERS (2009)
Circulating insulin-like growth factor I and cognitive function: Neuromodulation throughout the lifespan
Andre Aleman et al.
PROGRESS IN NEUROBIOLOGY (2009)
Peripheral administration of a novel diketopiperazine, NNZ 2591, prevents brain injury and improves somatosensory-motor function following hypoxia-ischemia in adult rats
J. Guan et al.
NEUROPHARMACOLOGY (2007)
Vascular health and longitudinal changes in brain and cognition in middle-aged and older adults
Naftali Raz et al.
NEUROPSYCHOLOGY (2007)
Delayed peripheral administration of a GPE analogue induces astrogliosis and angiogenesis and reduces inflammation and brain injury following hypoxia-ischemia in the neonatal rat
Pernilla Svedin et al.
DEVELOPMENTAL NEUROSCIENCE (2007)
Plasma IGF-I levels and cognitive performance in older women
Olivia Okereke et al.
NEUROBIOLOGY OF AGING (2007)
Midlife plasma insulin-like growth factor I and cognitive function in older men
Olivia I. Okereke et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging
WE Sonntag et al.
AGEING RESEARCH REVIEWS (2005)
Central penetration and stability of N-terminal tripeptide of insulin-like growth factor-I, glycine-proline-glutamate in adult rat
AM Baker et al.
NEUROPEPTIDES (2005)
Insulin-like growth factor I is required for vessel remodeling in the adult brain
C Lopez-Lopez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Neuroprotective effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate (GPE) following intravenous infusion in hypoxic-ischemic adult rats
J Guan et al.
NEUROPHARMACOLOGY (2004)
Insulin-like growth factor-1 and post-ischemic brain injury
J Guan et al.
PROGRESS IN NEUROBIOLOGY (2003)
Time- and cell type-specific induction of platelet-derived growth factor receptor-β during cerebral ischemia
O Renner et al.
MOLECULAR BRAIN RESEARCH (2003)
Proline-containing dipeptide GVS-111 retains nootropic activity after oral administration
RU Ostrovskaya et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2001)
The acid-labile subunit (ALS) of the 150 kDa IGF-binding protein complex: an important but forgotten component of the circulating IGF system
YR Boisclair et al.
JOURNAL OF ENDOCRINOLOGY (2001)
Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities
RC Baxter
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2000)
Share Paper
